| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.5196 | 20 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.2482 | 38 |
| GSM780709 | Untreated after 4 days (C3_1) | 35.2328 | 1 |
| GSM780719 | Untreated after 4 days (C1_2) | 39.5637 | 5 |
| GSM780720 | Untreated after 4 days (C2_2) | 41.5571 | 11 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.1251 | 10 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.6701 | 35 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.111 | 14 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 38.9788 | 4 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.1403 | 7 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.7895 | 16 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.3323 | 24 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.5186 | 5 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.5189 | 20 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.3221 | 14 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.1623 | 10 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 39.8104 | 6 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 39.8178 | 6 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.3526 | 7 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.5919 | 16 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 39.7943 | 6 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.45 | 11 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.1171 | 33 |